Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MENLO PARK, Calif., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the second quarter ended June 30, 2010. Net income for the three months ended...
-
MENLO PARK, Calif., Aug. 3, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that pursuant to the Hatch-Waxman Act, the 45-day period for filing a patent infringement suit under...
-
MENLO PARK, Calif., July 29, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that it will release second quarter 2010 financial results after the market closes Thursday, August 5,...
-
MENLO PARK, Calif., June 28, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received a $10 million milestone payment from Abbott Products, Inc., its licensee of...
-
MENLO PARK, Calif., June 7, 2010 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that the New Drug Application (NDA) for DM-1796 was accepted by the U.S. Food and Drug Administration...